Lancet Oncol 2004, 5 (7) : 430–442 CrossRefPubMed 5

Lancet Oncol 2004, 5 (7) : 430–442.CrossRefPubMed 5. Taniyama Y, Suzuki T, Mikami Y, Moriya T, Satomi S, EPZ015938 mw Sasano H: Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study. Endocr J 2005, 52 (5) : 605–611.CrossRefPubMed 6. Patel YC: Somatostatin and its receptor family. Front Neuroendocrinol 1999, 20 selleck chemicals llc (3) : 157–198.CrossRefPubMed 7. Reubi JC, Schaer JC, Laissue JA, Waser B: Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism 1996, 45 (8 Suppl 1) : 39–41.CrossRefPubMed 8. Reubi JC, Waser B, Horisberger U, Krenning E, Lamberts SW, Gebbers JO, Gersbach P, Laissue JA: In vitro autoradiographic and

in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood 1993, 82 (7) : 2143–2151.PubMed 9. Ferone D, van Hagen PM, Semino C, Dalm VA, Barreca A, Colao A, Lamberts SW, Minuto F, Hofland LJ: Somatostatin receptor distribution and function in immune system. Dig Liver Dis 2004, 36 (Suppl 1) : S68–77.CrossRefPubMed 10. Dutour A, Kumar U, Panetta R, Ouafik L, Fina F, Sasi R, Patel YC: Expression of somatostatin receptor subtypes in human brain tumors. Int J Cancer 1998, 76 (5) : 620–627.CrossRefPubMed 11. Schally AV: Oncological Foretinib applications of somatostatin analogues. Cancer Res 1988, 48 (24 Pt 1) : 6977–6985.PubMed

12. Susini C, Buscail L: Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol 2006, 17 (12) : 1733–1742.CrossRefPubMed 13. Lichtenauer-Kaligis EG, Dalm VA, Oomen SP, Mooij DM, van Hagen PM, Lamberts SW, Hofland LJ:

Differential expression of somatostatin receptor subtypes in human peripheral blood mononuclear cell subsets. Eur J Endocrinol 2004, 150 (4) : 565–577.CrossRefPubMed 14. Rosskopf D, Schurks M, Manthey I, Joisten M, Busch S, Siffert W: Signal transduction of somatostatin in human B lymphoblasts. Am J Physiol Cell Physiol 2003, 284 (1) : C179–190.PubMed 15. Ferone D, Resmini E, Boschetti M, Arvigo M, Albanese V, Ceresola E, Pivonello R, Albertelli M, Bianchi F, Giusti Amobarbital M, et al.: Potential indications for somatostatin analogues: immune system and limphoproliferative disorders. J Endocrinol Invest 2005, 28 (11 Suppl International) : 111–117.PubMed 16. Hatzoglou A, Kampa M, Castanas E: Opioid-somatostatin interactions in regulating cancer cell growth. Front Biosci 2005, 10: 244–256.CrossRefPubMed 17. Duran-Prado M, Malagon MM, Gracia-Navarro F, Castano JP: Dimerization of G protein-coupled receptors: New avenues for somatostatin receptor signalling, control and functioning. Mol Cell Endocrinol 2008, 286 (1–2) : 63–68.CrossRefPubMed 18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162 (1) : 156–159.CrossRefPubMed 19.

Comments are closed.